MAP2K7 and Insulin resistance: Taken together, the results show that inhibition of the MEK/ERK pathway improves insulin resistance not only by down‐regulating PPARγ phosphorylation, but also through PPARγ‐independent reduction of inflammatory cytokine secretion by adipocytes and monocytes.